Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin.
Rodriguez
J C
JC
Garcia-Pachon
E
E
Flores
E
E
Escribano
I
I
Ruiz
M
M
Royo
G
G
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001372:Aza Compounds / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage*; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones; D006801:Humans; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D009154:Mutation; D016926:Mycobacterium chelonae / Q000187:drug effects* / Q000235:genetics; D019907:Mycobacterium fortuitum / Q000187:drug effects* / Q000235:genetics; D011804:Quinolines / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D017291:Clarithromycin; D000077266:Moxifloxacin